Forecast & Rating6 analysts currently cover Adverum Biotech, with about 33.3% giving a positive rating — meaning they expect the stock to rise. For you, this means most institutions are cautious on Adverum Biotech's outlook. Data as of Dec 8, 2025; for reference only and not investment advice.
Nov 17, 2025Price forecast
--100.00%
Forecast & RatingBuy
6analysts
- Strong buy33.33%
- Buy0.00%
- Hold66.67%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateDec 7, 2025
Forecast met0.0%
Stock price$4.36
Avg. target$0.0
High target$6
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.